Mirjam J. Knol

Best Publications

• Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.

  Inge M. Haeck;Mirjam J. Knol;Onno ten Berge;Sara G.A. van Velsen

  221
  Citations

• Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

  Unknown

  217
  Citations

• Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

  Unknown

  203
  Citations

• Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

  Germaine Hanquet;Pavla Krizova;Palle Valentiner-Branth;Shamez N. Ladhani

  172
  Citations

• The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model

  Rob J.B. Klemans;Dianne Otte;Mirjam Knol;Edward F. Knol

  167
  Citations

• Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.

  Unknown

  129
  Citations

• Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

  Bernhard Ultsch;Oliver Damm;Phillippe Beutels;Joke Bilcke

  128
  Citations

• Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

  Mirjam J Knol;Susan J M Hahné;Jay Lucidarme;Helen Campbell

  103
  Citations

• Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.

  Mirjam J Knol;Gertjan H J Wagenvoort;Elisabeth A M Sanders;Karin Elberse

  101
  Citations

• Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

  Cees van Nieuwkoop;Willize E. van der Starre;Janneke E. Stalenhoef;Anna M. van Aartrijk

  101
  Citations

• E‐health in caring for patients with atopic dermatitis: a randomized controlled cost‐effectiveness study of internet‐guided monitoring and online self‐management training

  Unknown

  97
  Citations

• Large ongoing measles outbreak in a religious community in the Netherlands since May 2013.

  Unknown

  93
  Citations

• Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

  Judith Spijkerman;Reinier H. Veenhoven;Alienke J. Wijmenga-Monsuur;Karin E. M. Elberse

  92
  Citations

• Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.

  M. de Graaf;M.F. Raphael;C.C. Breugem;M.J. Knol

  89
  Citations

• Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.

  Brechje de Gier;Stijn Andeweg;Rosa Joosten;Ronald Ter Schegget

  86
  Citations

• Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.

  Daan Barug;Inge Pronk;Marlies A. van Houten;Florens G. A. Versteegh

  85
  Citations

• Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024

  Unknown

  75
  Citations

• Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

  Unknown

  73
  Citations

• Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.

  Mirjam J. Knol;Wilhelmina L. M. Ruijs;Laura Antonise-Kamp;Hester E. de Melker

  69
  Citations

• Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.

  Brechje de Gier;Stijn Andeweg;Jantien A Backer;Rivm Covid surveillance

  67
  Citations